Why the study?
These recommendations update the 2008 guidelines given the absence of adequately designed randomized clinical trials for the diagnosis and treatment of von Willebrand disease.
The 2022 Polish guidelines provide updated, expert-consensus recommendations for the complex laboratory diagnosis and clinical management of von Willebrand disease.
Answers are grounded in this paper and cite their sources.
Polish clinicians should adopt these vWD recommendations immediately; extends prior international guidelines with updated expert consensus.
Recommendations of the Group on Hemostasis of the Polish Society of Hematology and Transfusiology are an update of the guidelines issued in 2008 [1]. In the absence of adequately designed randomized clinical trials for the diagnosis and treatment of von Willebrand disease, these recommendations are largely based on retrospective studies, expert opinions, series of case reports as well as guidelines published in other countries. In questionable cases, most conclusive for the final diagnosis of von Willebrand disease (VWD) is the physician’s experience and his assessment of the patient’s clinical picture.
No takes yet. Share an insight, caveat, or question.
Zdziarska et al. (2022) conducted a review in von Willebrand disease. Clinical guidelines for diagnosis and management was evaluated. Updated guidelines from the Polish Society of Hematology and Transfusiology provide comprehensive recommendations for the diagnosis, classification, and management of von Willebrand disease.
Synapse has enriched 10 related papers. Consider them for comparative context: